Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Sinopharm Accord(000028) the EPS is 0.52 (-6.23%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
20.00B8.07%
----
EPSMiss expectations
0.526.23%
0.534.43%
-0.01001.80%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf